Efficiency of rituximab in the treatment of autoimmune thrombocytopenic purpura associated with common variable immunodeficiency [3]

American Journal of Hematology

Volumn 81, Issue 8, 2006, Pages 645-646

  Mahevas M ^a   Le Page, L ^a   Salle, V ^a   Cevallos, R ^a   Smail, A ^a   Duhaut, P ^a   Ducroix, J P ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; IMMUNOGLOBULIN; METHOTREXATE; RITUXIMAB; STEROID; VINCRISTINE;

AUTOIMMUNE DISEASE; BONE MARROW BIOPSY; CASE REPORT; CHILD; COMMON VARIABLE IMMUNODEFICIENCY; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; HUMAN; LETTER; PRIORITY JOURNAL; RELAPSE; STEROID THERAPY; THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; CHILD; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; HUMANS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; TREATMENT OUTCOME;

EID: 33746010567     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20619     Document Type: Letter

References (5)

1. Cunningham-Rundles C. Hematologic complications of primary immunodeficiencies. Blood 2002;16:1661-1664.
2. Michel M, Chanet V, Galicier L, et al. Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature. Medicine 2004;83:254-263.
3. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999;92:34-48.
4. Hermans PE, Diaz-Buxo JA, Stobo JD. Idiopathic late onset immunoglobulin deficiency. Clinical observations in 50 patients. Am J Med 1976;61:221-237.
5. Wakim M, Shah An Arndt PA, Garratty G, Weinberg K, Hofstra T, Chruch J. Successful anti-CD2Q monoclonal antibody treatment of severe autoimmune hemolytic anemia due to warm reactive IgM autoantibody in a child with common variable immunodeficiency. Am J Hematol 2004;76:152-155.